Kenneth Dandurand, Co-founder/Chief Executive Officer of Clinical Pharmacy Associates, Inc. and President of MedNovations, Inc., received his B.S. in Pharmacy from Northeastern University, Boston, and completed graduate training in hospital pharmacy and business management from Oregon State University and an ASHP-approved residency at Good Samaritan Hospital in Portland, Oregon.

His clinical pharmacy experience in community, hospital and managed care settings includes his roles as leader of the pediatric OB/GYN satellite pharmacy at Massachusetts General Hospital and director of the Pharmacy Department of Greater Southeast Community Hospital in Washington, D.C. Ken has initiated innovative professional programs by developing an extensive clinical pharmacy and drug information services and by spearheading the development of a model for standardized pharmacoeconomic analyses and quality improvement tools to improve the medication use process. He has served on national pharmacy and therapeutics committees for Rx Management, Pharmacy Direct Network and Blue Cross Blue Shield Federal Employees Program.

Ken currently holds an adjunct faculty appointment at Howard University College of Pharmacy, Nursing and Allied Health Science and is a clinical faculty member of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). His published work includes a chapter on medication safety in Misadventures in Health Care: Inside Stories, published in 2004.


Dr. Christopher A. Keeys, Co-founder/President of Clinical Pharmacy Associates, Inc. and CEO of MedNovations, Inc., is a licensed clinical pharmacist, pharmacy executive, researcher and educator who received his B.S. in Pharmacy from Howard University College of Pharmacy and a Doctor of Pharmacy degree from Philadelphia College of Pharmacy. He is board certified in Pharmacotherapy.

Chris completed his advanced training as a research intern with the Food and Drug Administration and as a clinician at the Washington Hospital Center. His professional accomplishments include directing the clinical drug studies for a Washington-area research group and leading innovative clinical pharmacy, pharmacy management, drug information and telepharmacy services at more than 60 governmental, private, academic and nonprofit organizations in the USA and internationally.

Chris has served on the Boards of the Washington Metropolitan Society of Hospital Pharmacists (President), the Drug Use Review Board for Washington, D.C., and the Chesapeake Research Review, Inc. He has also been a member of the Agency for Healthcare Policy and Research Group on Clinical Practice Guidelines. Since 1996 he has served as a senior pharmacy consultant to the BCBSA Federal Employee Program. Chris is a clinical preceptor for the University of Maryland and holds an adjunct associate professor faculty appointment at Howard University College of Pharmacy, Nursing and Allied Health Science. He has served as a clinical consultant to the DC Department of Health Administration for HIV/AIDS Policy and Programs and the Medicaid Program. He serves as a research fellow at the Howard University Center for Minority Studies and Healthcare Services and is a member of the National Academy of Practitioners. He has lectured and published in the areas of drug information, pharmacy practice, therapeutics, quality improvement, medication errors, formulary management, telepharmacy and patient safety.